Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Financial News

Decheng backs Nanjing Bioheng in series A

February 15, 2019 6:37 PM UTC

Nanjing Bioheng Biotech Co., Ltd. (Nanjing, China) raised RMB100 million ($14.8 million) in a series A round financing. Decheng Capital was the sole investor.

Founded in 2017, Nanjing Bioheng is developing immunotherapies and next-generation gene therapies for cancer and other diseases. Its pipeline includes six off-the-shelf allogeneic CAR T cell therapies in preclinical testing for various cancers...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article